ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.460
+0.120 (8.96%)
At close: Mar 9, 2026, 4:00 PM EDT
1.480
+0.020 (1.37%)
After-hours: Mar 9, 2026, 5:35 PM EDT
ABVC BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 36 | 50 | 7 | 9 | 20 | 96 | |
| Market Cap Growth | 374.69% | 594.95% | -19.29% | -55.74% | -78.95% | -8.30% | |
| Enterprise Value | 36 | 55 | 9 | 12 | 22 | 95 | |
| Last Close Price | 1.34 | 2.13 | 0.59 | 1.16 | 6.25 | 33.90 | |
| PS Ratio | - | - | 14.18 | 58.72 | 20.85 | 269.96 | |
| PB Ratio | 2.93 | 3.78 | 9.98 | 7.14 | 6.25 | 10.83 | |
| P/TBV Ratio | 2.98 | 4.52 | 5.89 | 5.76 | 6.53 | 10.86 | |
| EV/Sales Ratio | - | - | 18.41 | 80.24 | 22.60 | 266.23 | |
| Debt / Equity Ratio | 0.26 | 0.26 | 4.41 | 2.21 | 1.06 | 0.38 | |
| Net Debt / Equity Ratio | 0.21 | 0.21 | 3.98 | 2.10 | 1.00 | -0.29 | |
| Net Debt / EBITDA Ratio | -0.38 | -0.38 | -0.62 | -0.39 | -0.22 | 0.22 | |
| Net Debt / FCF Ratio | -0.91 | -0.91 | -1.59 | -0.62 | -0.43 | 0.34 | |
| Asset Turnover | - | - | 0.07 | 0.02 | 0.08 | 0.03 | |
| Inventory Turnover | - | - | - | - | - | 0.39 | |
| Quick Ratio | 0.25 | 0.25 | 0.05 | 0.03 | 0.18 | 1.72 | |
| Current Ratio | 0.41 | 0.41 | 0.33 | 0.27 | 0.54 | 2.07 | |
| Return on Equity (ROE) | -119.49% | -119.49% | -531.91% | -368.89% | -269.48% | -208.73% | |
| Return on Assets (ROA) | -31.25% | -31.25% | -38.38% | -48.71% | -81.16% | -57.83% | |
| Return on Capital Employed (ROCE) | -48.00% | -48.00% | -478.90% | -402.20% | -374.50% | -117.00% | |
| Earnings Yield | -23.88% | -15.75% | -67.87% | -87.01% | -81.21% | -13.37% | |
| FCF Yield | -9.02% | -5.95% | -25.04% | -47.01% | -37.18% | -7.93% | |
| Buyback Yield / Dilution | -72.25% | -72.25% | -169.26% | -36.92% | -26.39% | -27.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.